Portfolio Holdings Detail for ISIN GB0001990497
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
Stock Name / FundCity Of London Investment Trust
Issuer
Common Stock TickerCTY(GBX) LSE
Common Stock TickerCLN(EUR) F
Common Stock TickerCTY.LS(GBX) CXE
Common Stock TickerCTY.L(GBP) LSE

Holdings detail for JNJ

Stock NameJohnson & Johnson
TickerJNJ(EUR) F
TYPECommon Stock
CountryGermany
ISINUS4781601046
LEI549300G0CFPGEF6X2043

Show aggregate JNJ holdings

News associated with JNJ

Fund Update: Mediolanum International Funds Ltd Just Disclosed New Holdings
Mediolanum International Funds Ltd just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-05-07 13:57:40
Should WisdomTree U.S. Total Dividend ETF (DTD) Be on Your Investing Radar?
Style Box ETF report for DTD - 2025-05-07 10:20:06
Fund Update: PINNACLE ASSOCIATES LTD Just Disclosed New Holdings
PINNACLE ASSOCIATES LTD just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-05-06 18:20:59
Do Wall Street Analysts Like Johnson & Johnson Stock?
Although Johnson & Johnson has lagged behind the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. - 2025-05-06 15:48:05
IXUS, FMTM: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the iShares Core MSCI Total International Stock ETF, which added 19,000,000 units, or a 3.3% increase week over week. Among the largest underlying com - 2025-05-05 14:53:52
DGRO, JPM, JNJ, AVGO: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Dividend Growth ETF (Symbol: DGRO) where we have detected an approximate $258.4 million dollar inflow -- that's a 0.9% increase week ove - 2025-05-05 14:50:51
Nanobiotix Reveals Favorable Results Of JNJ-1900 Study Pancreatic Cancer; Seeks Further Evaluation
(RTTNews) - Nanobiotix S.A. (NBTX), a biotechnology company focused on nanoparticle-based cancer treatments, announced Monday positive full results from the completed dose escalation and dose expansion phases of a Phase 1 study evaluating JNJ-1900 (NBTXR3) in patients with locall - 2025-05-05 07:42:50
Do Wall Street Analysts Like Pfizer Stock?
Pfizer has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects. - 2025-05-01 17:42:48
Do Wall Street Analysts Like Pfizer Stock?
Pfizer has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects. - 2025-05-01 15:58:47
Is WisdomTree U.S. Total Dividend ETF (DTD) a Strong ETF Right Now?
Smart Beta ETF report for DTD - 2025-05-01 10:20:05
The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis
Amazon, Johnson & Johnson, Cisco Systems and NeurAxis are included in this Analyst Blog. - 2025-05-01 08:49:00
What's Next For Pfizer Stock After A Mixed Q1?
Pfizer stock (NYSE: PFE) recently reported its Q1 results, with revenues missing and earnings exceeding the street estimates. The company reported revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to the consensus estimates of $14.1 billion and $0.68, re - 2025-05-01 02:34:47
Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and Cisco Systems, Inc. (CSCO), as well as a micro-cap NeurAxis, Inc. (NRXS). - 2025-04-30 21:02:00
Fund Update: Bank of New York Mellon Corp Just Disclosed New Holdings
Bank of New York Mellon Corp just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-04-29 14:39:29
How Will Pfizer Stock React To Its Upcoming Earnings?
Pfizer (NYSE:PFE) is scheduled to report earnings on Tuesday, April 29, 2025. Looking at PFE’s five-year history, the stock has shown an exact 50-50 split between positive and negative returns following earnings announcements. When positive, the stock has delivered a median - 2025-04-28 03:42:13
Fund Update: BARTLETT & CO. WEALTH MANAGEMENT LLC Just Disclosed New Holdings
BARTLETT & CO. WEALTH MANAGEMENT LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-04-24 15:20:15
In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right Now
Every so often, Wall Street offers a reminder to investors that, despite popular belief, stocks don't rise in a straight line. Although the annualized return of stocks over the last century trumps all other asset classes, corrections, bear markets, and even crashes are normal, he - 2025-04-24 07:51:00
How Will Bristol Myers Squibb Stock React To Its Upcoming Earnings?
Bristol Myers Squibb (NYSE:BMY) is scheduled to release its earnings report on Thursday, April 24, 2025. Examining its historical performance, BMY stock has shown a tendency for negative reactions following earnings announcements. Over the past five years, the stock has experienc - 2025-04-24 04:57:59
How Will Merck Stock React To Its Upcoming Earnings?
Merck (NYSE:MRK) is scheduled to release its earnings report on Thursday, April 24, 2025. Historical data suggests a potential negative reaction in MRK stock following the announcement. Over the past five years, the stock has experienced a negative one-day return after earnings i - 2025-04-24 04:57:58
How Did JNJ Fare In Q1?
Johnson & Johnson (NYSE: JNJ) recently reported its Q1 results, with revenues and earnings exceeding the street estimates. The company reported strong adjusted earnings of $2.77 per share on revenue of $21.9 billion, surpassing analysts’ expectations of $2.59 per share - 2025-04-21 06:34:13
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government
In 2011, following the difficulty caused by the Great Recession, S&P Global Ratings (formerly Standard & Poor's) downgraded the long-term credit outlook of the United States from its highest designation of AAA to AA+, citing budgetary issues. Fitch once again downgraded U - 2025-04-20 11:30:00
Johnson & Johnson (NYSE:JNJ) Shares Up 0.4% Following Earnings Beat
Shares of Johnson & Johnson (NYSE:JNJ – Get Free Report) were up 0.4% on Wednesday after the company announced better than expected quarterly earnings. The stock traded as high as $155.63 and last traded at $154.29. Approximately 1,979,675 shares changed hands during mid-day trading, a decline of 80% from the average daily volume of 9,843,281 […] - 2025-04-18 05:09:04
Notable ETF Inflow Detected - IWD, JPM, WMT, JNJ
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $667.9 million dollar inflow -- that's a 1.2% increase week over w - 2025-04-17 15:10:35
Fund Update: FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ Just Disclosed New Holdings
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by othe - 2025-04-16 11:41:31
Johnson & Johnson (NYSE:JNJ) Shares Down 0.7% Following Analyst Downgrade
Johnson & Johnson (NYSE:JNJ – Get Free Report) shares were down 0.7% on Tuesday after Raymond James lowered their price target on the stock from $165.00 to $162.00. Raymond James currently has an outperform rating on the stock. Johnson & Johnson traded as low as $152.10 and last traded at $153.27. Approximately 3,332,488 shares changed […] - 2025-04-16 05:44:48
Johnson & Johnson (NYSE:JNJ) Given New $162.00 Price Target at Raymond James
Johnson & Johnson (NYSE:JNJ – Free Report) had its price target trimmed by Raymond James from $165.00 to $162.00 in a report published on Monday,Benzinga reports. The firm currently has an outperform rating on the stock. Several other analysts also recently weighed in on the company. The Goldman Sachs Group upgraded Johnson & Johnson from […] - 2025-04-15 07:41:00
Congressmember Josh Gottheimer's New Portfolio Holdings
Quiver's Josh Gottheimer Strategy is an automated trading strategy that tracks the performance of stocks that are being held by U.S. Congressmember Josh Gottheimer (or their family).This strategy is rebalanced when new trades or annual reports are reported. The strategy has retur - 2025-04-14 20:00:07
JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview
JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article. - 2025-04-14 07:22:00
Congressmember Shelley Moore Capito's New Portfolio Holdings
Quiver's Shelley Moore Capito Strategy is an automated trading strategy that tracks the performance of stocks that are being held by U.S. Congressmember Shelley Moore Capito (or their family).This strategy is rebalanced when new trades or annual reports are reported. The strategy - 2025-04-11 20:00:07
5 Dividend Aristocrats Where Analysts See Capital Gains
To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to attract a lot of investor attention — - 2025-04-11 12:16:16

City Of London Investment Trust JNJ holdings

DateNumber of JNJ Shares HeldBase Market Value of JNJ SharesLocal Market Value of JNJ SharesChange in JNJ Shares HeldChange in JNJ Base ValueCurrent Price per JNJ Share HeldPrevious Price per JNJ Share Held
2024-01-31 (Wednesday)104,000USD 12,971,314USD 10,380,000
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of JNJ

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-091,303,4235342,276,57557.3%
2025-05-081,520,1257872,761,13955.1%
2025-05-071,419,8452,6312,670,16653.2%
2025-05-061,769,7802,5383,077,20957.5%
2025-05-05952,0632,0601,821,56352.3%
2025-05-02888,9141,4112,265,33939.2%
2025-05-011,251,2493,1252,205,56556.7%
2025-04-30887,0611,7382,089,88842.4%
2025-04-29882,1482,9871,729,33651.0%
2025-04-281,267,0621,0782,366,56853.5%
2025-04-251,281,5637,4632,990,60542.9%
2025-04-241,271,9758503,632,85335.0%
2025-04-231,529,0936322,925,76352.3%
2025-04-221,036,1233,3172,421,16342.8%
2025-04-211,162,3045,6802,308,45550.3%
2025-04-171,587,5812,3363,539,86244.8%
2025-04-161,375,2071,3532,686,54451.2%
2025-04-151,758,4207,7303,912,43844.9%
2025-04-141,419,9625,0213,707,88138.3%
2025-04-111,395,6987,8033,231,36243.2%
2025-04-102,401,6664,6084,729,90550.8%
2025-04-092,548,1016,8716,246,97340.8%
2025-04-081,213,5478743,617,46633.5%
2025-04-071,906,0286,5746,201,49630.7%
2025-04-041,735,5607,4004,779,42136.3%
2025-04-032,487,1493,3014,981,20249.9%
2025-04-021,359,2573,6913,348,49240.6%
2025-04-013,443,0907,4997,121,43848.3%
2025-03-311,258,9682,5653,166,60239.8%
2025-03-28957,5773,4261,803,06153.1%
2025-03-271,160,0843,1332,051,56956.5%
2025-03-26969,589372,411,88640.2%
2025-03-251,047,7736,6292,324,62645.1%
2025-03-24989,4964,5222,291,02643.2%
2025-03-211,480,6563872,451,51660.4%
2025-03-201,026,7731,3262,002,40651.3%
2025-03-19834,0692,6981,604,79852.0%
2025-03-181,434,2174,4852,482,39357.8%
2025-03-17967,9175,7032,037,36647.5%
2025-03-141,039,9068,0982,170,71947.9%
2025-03-13833,3542,4701,990,25141.9%
2025-03-121,194,5821,7192,805,03542.6%
2025-03-111,551,1645,3503,037,40651.1%
2025-03-102,461,31310,9306,358,65538.7%
2025-03-071,064,53010,6102,913,55836.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.